Table 2A.
Factors associated with steatosis—univariate analysis
| Factor | Steatosis (n=64) | No Steatosis (n=84) | Duration of FU-Unadjusted p value | Duration of FU-Adjusted p value |
|---|---|---|---|---|
| Underlying diagnosis (HCV vs NASH) | 17 (26.6) | 36 (42.9) | 0.041 | 0.33 |
| Male | 47 (73.4) | 65 (77.4) | 0.58 | 0.32 |
| Caucasian | 52 (81.3) | 67 (79.8) | 0.82 | 0.65 |
| Age | 55.0 (50.7, 59.0) | 56.0 (50.0, 63.0) | 0.38 | 0.34 |
| Triglyceride | 157.0 (115.0, 219.0) | 153.0 (101.0, 206.0) | 0.65 | 0.56 |
| HDL | 42.0 (34.0, 50.0) | 46.0 (39.0, 53.0) | 0.14 | 0.19 |
| Tacrolimus | 56 (87.5) | 72 (85.7) | 0.75 | 0.56 |
| Cyclosporine | 5 (7.8) | 8 (9.5) | 0.72 | 0.41 |
| Mycophenolate mofetil | 25 (39.1) | 28 (33.3) | 0.47 | 0.12 |
| Diabetes post-OLT | 39 (60.9) | 48 (57.1) | 0.64 | 0.21 |
| Hypertension post-OLT | 37 (57.8) | 52 (61.9) | 0.61 | 0.65 |
| BMI @1 yr post-OLT | 28.4 (25.0, 31.6) | 28.7 (24.0, 32.1) | 0.97 | 0.97 |
| MS @1 yr post-OLT | 31 (53.5) | 34 (52.3) | 0.9 | 0.66 |
| Acute cellular rejection | 26 (40.6) | 39 (46.4) | 0.48 | 0.16 |
| Steroids | 17 (27.4) | 17 (20.7) | 0.35 | 0.99 |
Values are presented as n(%) or median (25%ile, 75%ile)
Unadjusted p values correspond to Pearson’s χ2 tests for categorical factors and Wilcoxon rank sum tests for continuous variables. Adjusted p values correspond to logistic regression analysis adjusting for time between OLT and last biopsy.